ArticleFrontiers in cell and developmental biology2021

miR-26a Reverses Multidrug Resistance in Osteosarcoma by Targeting MCL1.

Ming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.